Publication

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization

Dorbala, S., Ando, Y., Bokhari, S., Dispenzieri, A., Falk, R. H., Ferrari, V. A., Fontana, M., Gheysens, O., Gillmore, J. D., Glaudemans, A. W. J. M., Hanna, M. A., Hazenberg, B. P. C., Kristen, A. V., Kwong, R. Y., Maurer, M. S., Merlini, G., Miller, E. J., Moon, J. C., Murthy, V. L., Quarta, C. C., Rapezzi, C., Ruberg, F. L., Shah, S. J., Slart, R. H. J. A., Verberne, H. J. & Bourque, J. M., Nov-2019, In : JOURNAL OF CARDIAC FAILURE. 25, 11, p. 854-865 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • ASNC_AHA_ASE_EANM_HFSA_ISA_SCMR_SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis_ Part 2 of 2—Diagnostic Criteria and Appropriate Utilization _

    Final publisher's version, 8 MB, PDF document

    Request copy

DOI

  • Sharmila Dorbala
  • Yukio Ando
  • Sabahat Bokhari
  • Angela Dispenzieri
  • Rodney H. Falk
  • Victor A. Ferrari
  • Marianna Fontana
  • Olivier Gheysens
  • Julian D. Gillmore
  • Andor W. J. M. Glaudemans
  • Mazen A. Hanna
  • Bouke P. C. Hazenberg
  • Arnt V. Kristen
  • Raymond Y. Kwong
  • Mathew S. Maurer
  • Giampaolo Merlini
  • Edward J. Miller
  • James C. Moon
  • Venkatesh L. Murthy
  • C. Cristina Quarta
  • Claudio Rapezzi
  • Frederick L. Ruberg
  • Sanjiv J. Shah
  • Riemer H. J. A. Slart
  • Hein J. Verberne
  • Jamieson M. Bourque

Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.

Original languageEnglish
Pages (from-to)854-865
Number of pages12
JournalJOURNAL OF CARDIAC FAILURE
Volume25
Issue number11
Early online date9-Aug-2019
Publication statusPublished - Nov-2019

    Keywords

  • Cardiac amyloidosis, diagnosis, appropriate use, expert consensus, multimodality, BRAIN NATRIURETIC PEPTIDE, LIGHT-CHAIN AMYLOIDOSIS, ASSOCIATION TASK-FORCE, AMERICAN-COLLEGE, HEART-FAILURE, MAGNETIC-RESONANCE, STAGING SYSTEM, AL, CARDIOLOGY, DIAGNOSIS

ID: 95758864